University of West Attica
Εμβολιασμός κατά της λοίμωξης από τον ιό της γρίπης στην κύηση και η ανοσολογική απάντηση στο νεογνό: η επίδραση των επαγγελματιών περιγεννητικής φροντίδας στη λήψη απόφασης
Abstract
dc:descriptionIntroduction: Ιmmunization during pregnancy is an important aspect of perinatal care. Special populations, such as pregnant women, are particularly vulnerable to infectious diseases due to changes in the immune, respiratory, and cardiovascular systems during pregnancy. Although the influenza vaccine during pregnancy is safe, vaccination rates remain low. According to previous studies Influenza infections during the perinatal period have been associated with more severe maternal and perinatal outcomes. For this reason, vaccination data in this population are crucial. According to the World Health Organization (WHO), all pregnant women and those of childbearing age should receive the inactivated influenza vaccine, irrespective of their pregnancy stage. Research data suggests that one of the reasons for low vaccination rates among pregnant women is that they do not receive a clear recommendation from health care providers. Aim – Material & Methods: In the first stage of the present research, the aim was to record knowledge and attitudes about influenza vaccination and to investigate the recommendation of vaccination by health professionals during the perinatal period. A cross-sectional survey was conducted from November 2020 to January 2021 in Athens. A total of 240 health professionals attended the study from different scientific fields, e.g., midwives, obstetricians–gynecologists, and pediatricians. Data were collected using an appropriate standardized questionnaire with information about demographics, attitudes towards influenza vaccination, and knowledge about the influenza virus and peripartum vaccination. Statistical analysis was conducted using IBM SPSS-Statistics version 26.0. The current research studies the level of knowledge and attitudes of healthcare professionals regarding influenza and perinatal influenza vaccination. Also, this study identifies the reasons for the lack of vaccine uptake including a wide range of misconceptions or lack of knowledge about influenza infection and how this may influence vaccination recommendations during pregnancy. The second part of this study aimed to elucidate factors influencing neonatal antibody presence following maternal influenza vaccination. Conducted from December 1, 2020 and August 31, 2022, through convenience sampling in Athens, the study involved 78 pregnant women who received flu vaccination. Participants completed questionnaires covering demographics, obstetric history, attitudes toward influenza vaccination, and knowledge about the influenza virus and pregnancy vaccination. Blood samples were collected from 83 neonates to assess IgG antibody presence. Five of the surveyed women had twin pregnancies. Using two commercially available enzyme-linked immunosorbent tests (ELISAs), the sera were qualitatively analyzed for the presence of IgG class antibodies against Influenza Virus A and Influenza Virus B. The relevant instructions for use (IFUs) were provided by the vendor. IBM SPSS-Statistics version 26.0 was used for the statistical analysis. Results: The study revealed the presence of positive influenza A (79.5%) and B (72.3%) antibodies in neonates following maternal immunization. Furthermore, the majority of neonates (60.2%) demonstrated positivity for both influenza A and B, while merely 3 neonates (0.04%) tested negative for both influenza A and B. In addition, our findings revealed a notably higher prevalence of positive results for influenza A antibodies within the neonates born between the 37th and 42nd week of gestation (p = 0.021), as well as among women vaccinated during the second trimester of pregnancy (p = 0.041). Furthermore, we observed a statistically significant correlation between the duration between vaccination and blood sampling and the presence of antibodies against influenza B. Participants who tested positive for influenza B antibodies exhibited a significantly shorter period between vaccination and blood sampling. Conclusion: This research identified the reasons for the lack of vaccine uptake among health care providers including misconceptions or lack of knowledge about influenza virus and influenza vaccination. In addition, our study revealed the presence of antibodies in neonates after maternal immunization. Furthermore, it identified factors that influenced the transfer of antibodies from mother to fetus. In conclusion, these findings offer valuable insights for healthcare professionals to provide informed recommendations on influenza vaccination during pregnancy and empower expectant mothers to make informed decisions about the benefits of immunization. Continuing professional education for health professionals is necessary to improve the level of knowledge, prevent negative beliefs, and promote preventive and therapeutic practices.
Degree
thesis:*- Grantor dc:publisher
- University of West Attica
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Taskou, Chrysoula
- Τάσκου, Χρυσούλα
Subjects
dc:subject × 18- Ιός της γρίπης
- Αντιγριπικό εμβόλιο
- Ανοσοποίηση
- Κύηση
- Νεογνό
- Influenza
- Vaccination
- Immunization
- Pregnancy
- Neonates
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Δημόσια/περιβαλλοντική υγεία και Υγεία της εργασίας
- Επιστήμες υγείας, άλλοι τομείς
- Health Sciences
- Medical and Health Sciences
- Public Health, Environmental and Occupational Health
- Health sciences, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/56644